Why the study?
Does the fixed combination of lercanidipine and enalapril effectively reduce blood pressure and improve vascular and renal outcomes in patients with arterial hypertension?
Does the fixed combination of lercanidipine and enalapril effectively reduce blood pressure and improve vascular and renal outcomes in patients with arterial hypertension?
The fixed combination of lercanidipine and enalapril is an effective and well-tolerated treatment for hypertension with potential vascular and renal benefits, aligning with current guidelines.
May support fixed lercanidipine-enalapril combinations; leaves open need for RCTs vs alternatives.
According to current international and national guidelines for the management of arterial hypertension preference is given to the use of fixed combinations of antihypertensive drugs of different classes, thus increasing the effectiveness of therapy acting in a complementary manner to affect different pathogenic mechanisms of arterial hypertension and reducing the frequency of side effects. A fixed combination of lercanidipine and enalapril contains antihypertensive drugs that have complementary mechanisms of action. This combination effectively reduces blood pressure, has high efficacy and tolerability, it may provide an additive effect on macro- and microvascular structures, arterial stiffness and oxidative stress. It has a beneficial influence on renal function, especially in patients with comorbidities.
No takes yet. Share an insight, caveat, or question.
P. О. Lazarev (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: